Your browser doesn't support javascript.
loading
Outcomes of transcutaneous retrobulbar Amphotericin B (TRAMB) as an adjuvant therapy for rhino-orbital-cerebral mucormycosis (ROCM) following COVID-19.
Shakrawal, Jyoti; Sharma, Vidhu; Goyal, Amit; Kumar, Deepak; Meena, Seema; Tiwari, Sarbesh; Jain, Vidhi; Elhence, Poonam; Soni, Kapil; Choudhury, Bikram; Bhatnagar, Kavita; Garg, Mahendra Kumar; Misra, Sanjeev.
Afiliação
  • Shakrawal J; Department of Ophthalmology, All India Institute of Medical Sciences (AIIMS), Jodhpur, Basni Phase-II, Jodhpur, Rajasthan, 342005, India.
  • Sharma V; Department of Otorhinolaryngology, All India Institute of Medical Sciences (AIIMS), Jodhpur, Basni Phase-II, Jodhpur, Rajasthan, 342005, India.
  • Goyal A; Department of Otorhinolaryngology, All India Institute of Medical Sciences (AIIMS), Jodhpur, Basni Phase-II, Jodhpur, Rajasthan, 342005, India.
  • Kumar D; Department of General Medicine, All India Institute of Medical Sciences (AIIMS), Jodhpur, Basni Phase-II, Jodhpur, Rajasthan, 342005, India.
  • Meena S; Department of Ophthalmology, All India Institute of Medical Sciences (AIIMS), Jodhpur, Basni Phase-II, Jodhpur, Rajasthan, 342005, India.
  • Tiwari S; Department of Diagnostic and Interventional Radiology, All India Institute of Medical Sciences (AIIMS), Jodhpur, Basni Phase-II, Jodhpur, Rajasthan, 342005, India.
  • Jain V; Department of Microbiology, All India Institute of Medical Sciences (AIIMS), Jodhpur, Basni Phase-II, Jodhpur, Rajasthan, 342005, India.
  • Elhence P; Department of Pathology and Lab Medicine, All India Institute of Medical Sciences (AIIMS), Jodhpur, Basni Phase-II, Jodhpur, Rajasthan, 342005, India.
  • Soni K; Department of Otorhinolaryngology, All India Institute of Medical Sciences (AIIMS), Jodhpur, Basni Phase-II, Jodhpur, Rajasthan, 342005, India.
  • Choudhury B; Department of Otorhinolaryngology, All India Institute of Medical Sciences (AIIMS), Jodhpur, Basni Phase-II, Jodhpur, Rajasthan, 342005, India.
  • Bhatnagar K; Department of Ophthalmology, All India Institute of Medical Sciences (AIIMS), Jodhpur, Basni Phase-II, Jodhpur, Rajasthan, 342005, India. rajankavita12@gmail.com.
  • Garg MK; Department of General Medicine, All India Institute of Medical Sciences (AIIMS), Jodhpur, Basni Phase-II, Jodhpur, Rajasthan, 342005, India.
  • Misra S; Department of Surgical Oncology, All India Institute of Medical Sciences (AIIMS), Jodhpur, Basni Phase-II, Jodhpur, Rajasthan, 342005, India.
Int Ophthalmol ; 43(6): 1919-1926, 2023 Jun.
Article em En | MEDLINE | ID: mdl-36427099
ABSTRACT

PURPOSE:

To assess the outcomes of transcutaneous retrobulbar Amphotericin B (TRAMB) for rhino-orbital-cerebral-mucormycosis (ROCM) post-COVID-19, as an adjuvant to standard systemic antifungal therapy.

METHODS:

In this prospective cohort study involving ROCM patients with clinical/radiological orbital involvement, 44 eyes with ROCM stage ≥ 3B received TRAMB for 7 consecutive days with liposomal Amphotericin-B (3.5 mg/ml) with a minimum clinical and radiological follow-up of 3 months. All patients received standard systemic antifungal therapy also as per institutional protocol. Data pertaining to demography, systemic status, clinical involvement, imaging, surgical/medical management were also recorded. Potential eyes for exenteration were excluded. Please confirm if the author names are presented accurately and in the correct sequence (given name, middle name/initial, family name). Author 12 Given name [Mahendra Kumar ] Last name [Garg]. Also, kindly confirm the details in the metadata are correct.All author names are presented accurately. Details in the metadata are correct. Thank you.

RESULTS:

Forty-four eyes of 42 patients were included, out of which 30 had diabetes mellitus & 22 had received steroid/oxygen treatment during COVID-19 infection. Forty eyes showed improvement or stable disease on follow-up on radiology. Four eyes which showed progression of the disease in orbit were reaugmented with TRAMB. No patient required exenteration. Subconjunctival haemorrhage occurred in six eyes and temporary blurring of vision in four eyes after TRAMB which resolved spontaneously.

CONCLUSION:

TRAMB, as an adjuvant to standard systemic antifungal therapy, is associated with a significant reduction or stabilisation of orbital involvement. TRAMB should be considered as an adjuvant therapy for ROCM to reduce disease progression as well as to preserve globe or sight. It has a promising role in preventing potential orbital exenterations.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Orbitárias / Oftalmopatias / COVID-19 / Mucormicose Tipo de estudo: Guideline / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Orbitárias / Oftalmopatias / COVID-19 / Mucormicose Tipo de estudo: Guideline / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article